Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Horak

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
Optics Express|May 3, 2018
Nonlinear dynamic of picosecond pulse propagation in atmospheric air-filled hollow core fibersSeyedmohammad Abokhamis Mousavi, Hans Christian Hansen Mulvad, Natalie V Wheeler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
BMC Medicine|October 24, 2022
Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boardsDamian T Rieke, Till de Bortoli, Peter Horak, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
International Journal of Cancer|September 19, 2020
Integrating proteomics into precision oncologyLeonie W Wahjudi, Stephan Bernhardt, Khalid Abnaof, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept studyMarie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
NPJ Precision Oncology|December 15, 2025
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
Optics Express|May 3, 2018
Nonlinear dynamic of picosecond pulse propagation in atmospheric air-filled hollow core fibersSeyedmohammad Abokhamis Mousavi, Hans Christian Hansen Mulvad, Natalie V Wheeler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
BMC Medicine|October 24, 2022
Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boardsDamian T Rieke, Till de Bortoli, Peter Horak, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 12, 2020
Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare diseaseAnne Katrin Berger, Sadaf Shabbir Mughal, Michael Allgäuer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
International Journal of Cancer|September 19, 2020
Integrating proteomics into precision oncologyLeonie W Wahjudi, Stephan Bernhardt, Khalid Abnaof, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept studyMarie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
NPJ Precision Oncology|December 15, 2025
Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.
Pageof 14